Naturhouse Health, S.A. (BME: NTH)
Spain
· Delayed Price · Currency is EUR 1.670
-0.005 (-0.30%)
Dec 20, 2024, 5:35 PM CET
Naturhouse Health Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 49.9 | 50.41 | 52.4 | 57.59 | 55.08 | 81.67 | Upgrade
|
| Revenue Growth (YoY) | -1.33% | -3.81% | -9.01% | 4.56% | -32.55% | -6.44% | Upgrade
|
| Cost of Revenue | 14.18 | 13.9 | 15.16 | 16.58 | 16.11 | 24.22 | Upgrade
|
| Gross Profit | 35.72 | 36.51 | 37.24 | 41.01 | 38.97 | 57.45 | Upgrade
|
| Selling, General & Admin | 13.21 | 12.6 | 14.62 | 14.97 | 16.25 | 26.64 | Upgrade
|
| Other Operating Expenses | 6.2 | 5.37 | 7.48 | 6.05 | 5.09 | 7.83 | Upgrade
|
| Operating Expenses | 21.56 | 20.23 | 24.4 | 23.47 | 24.6 | 38.76 | Upgrade
|
| Operating Income | 14.16 | 16.28 | 12.84 | 17.54 | 14.37 | 18.69 | Upgrade
|
| Interest Expense | -0.64 | -0.62 | -0.21 | -0.1 | -0.19 | -0.26 | Upgrade
|
| Interest & Investment Income | 0.25 | 0.04 | 0.11 | 0.36 | 0.02 | 0.13 | Upgrade
|
| Earnings From Equity Investments | 0.09 | -0.15 | 0.31 | 0.59 | 0.3 | 0.24 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.08 | -0.13 | 0.04 | 0.06 | 0.15 | -0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.17 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 13.61 | 15.43 | 13.09 | 18.45 | 14.66 | 18.75 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.02 | -0.01 | 0.01 | -0.21 | -1.15 | - | Upgrade
|
| Asset Writedown | - | - | - | - | - | 0.49 | Upgrade
|
| Pretax Income | 13.6 | 15.42 | 13.1 | 18.25 | 13.51 | 19.24 | Upgrade
|
| Income Tax Expense | 3.85 | 4.17 | 3.48 | 4.88 | 4.13 | 6.03 | Upgrade
|
| Earnings From Continuing Operations | 9.74 | 11.25 | 9.62 | 13.37 | 9.39 | 13.21 | Upgrade
|
| Minority Interest in Earnings | 0 | 0.05 | 0.01 | -0.01 | -0.01 | 0.05 | Upgrade
|
| Net Income | 9.74 | 11.29 | 9.63 | 13.36 | 9.38 | 13.26 | Upgrade
|
| Net Income to Common | 9.74 | 11.29 | 9.63 | 13.36 | 9.38 | 13.26 | Upgrade
|
| Net Income Growth | -6.17% | 17.31% | -27.95% | 42.46% | -29.25% | -13.76% | Upgrade
|
| Shares Outstanding (Basic) | 60 | 60 | 60 | 60 | 60 | 60 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 60 | 60 | 60 | 60 | 60 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | -0.03% | -0.03% | Upgrade
|
| EPS (Basic) | 0.16 | 0.19 | 0.16 | 0.22 | 0.16 | 0.22 | Upgrade
|
| EPS (Diluted) | 0.16 | 0.19 | 0.16 | 0.22 | 0.16 | 0.22 | Upgrade
|
| EPS Growth | -4.40% | 17.73% | -27.27% | 40.62% | -28.89% | -14.16% | Upgrade
|
| Free Cash Flow | 14.6 | 20.38 | 6.13 | 16.12 | 14.38 | 18.79 | Upgrade
|
| Free Cash Flow Per Share | 0.24 | 0.34 | 0.10 | 0.27 | 0.24 | 0.31 | Upgrade
|
| Dividend Per Share | - | - | 0.150 | 0.200 | 0.060 | 0.250 | Upgrade
|
| Dividend Growth | - | - | -25.00% | 233.33% | -76.00% | -10.71% | Upgrade
|
| Gross Margin | 71.58% | 72.42% | 71.06% | 71.21% | 70.75% | 70.35% | Upgrade
|
| Operating Margin | 28.38% | 32.29% | 24.51% | 30.46% | 26.09% | 22.89% | Upgrade
|
| Profit Margin | 19.53% | 22.40% | 18.37% | 23.20% | 17.03% | 16.23% | Upgrade
|
| Free Cash Flow Margin | 29.25% | 40.43% | 11.70% | 27.99% | 26.11% | 23.01% | Upgrade
|
| EBITDA | 14.71 | 16.83 | 13.37 | 19.86 | 17.47 | 22.9 | Upgrade
|
| EBITDA Margin | 29.49% | 33.39% | 25.52% | 34.48% | 31.72% | 28.04% | Upgrade
|
| D&A For EBITDA | 0.55 | 0.55 | 0.53 | 2.31 | 3.1 | 4.21 | Upgrade
|
| EBIT | 14.16 | 16.28 | 12.84 | 17.54 | 14.37 | 18.69 | Upgrade
|
| EBIT Margin | 28.38% | 32.29% | 24.51% | 30.46% | 26.09% | 22.89% | Upgrade
|
| Effective Tax Rate | 28.34% | 27.04% | 26.59% | 26.74% | 30.54% | 31.35% | Upgrade
|
| Advertising Expenses | - | 2.67 | 3.5 | 3.93 | 2.87 | 6.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.